VEREINIGTE STAATEN VON AMERIKA

DGAP-News: SleepX approved by the Helsinki Committee to conduct clinical trial with the SleepX PRO smartphone application

Retrieved on: 
Dienstag, Mai 31, 2022
An Act to exempt a particular class of securities from the Securities and Exchange Act, Smartphone, U.S. Securities and Exchange Commission, Sleep apnea, Growth hacking, Snoring, Insurance, OTC, Solution, Obesity, Clinical trial, Research, FDA, Norwegian Helsinki Committee, Awareness, Helsinki Committee for Human Rights, Forward-looking statement, Terminology, PRO, Technology, Degenerative disease, Sale, Immune system, CAGR, Founder, DreamIt Ventures, Diagnosis, Artificial intelligence, Security (finance), CEO, Sleep, Pharmaceutical industry, Medical device

SleepX, a subsidiary of AppYea (OTC: APYP) focusing on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, announces it received approval from the Helsinki Committee to begin its planned clinical trial on the SleepX PRO application.

Key Points: 
  • SleepX, a subsidiary of AppYea (OTC: APYP) focusing on the development of accurate wearable monitoring solutions to treat sleep apnea and snoring, announces it received approval from the Helsinki Committee to begin its planned clinical trial on the SleepX PRO application.
  • This follows the companys recent update that it intends to test the SleepX Pro application at a hospital sleep lab.
  • SleepX Pro, which is designed to diagnose sleep apnea using only a smartphone, requires no physical contact with the subject.
  • Neither APYP nor SLEEPX are subject to the reporting requirements of the Securities and Exchange Commission under the Securities and Exchange Act of 1934 as amended.

Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc

Retrieved on: 
Dienstag, Mai 31, 2022
The Vanguard Group, Disclosure, Security (finance), Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

DGAP-News: AmeraMex International Receives Orders Totaling $1.1 Million

Retrieved on: 
Dienstag, Mai 31, 2022
Company, Forestry, U.S. Securities and Exchange Commission, ASV, Review, Mining, Industry, Pacific Northwest, Technology, Security (finance), Twitter, OTCQB, Magni, Heavy equipment, Intermodal freight transport

AmeraMex International, Inc. (OTCQB: AMMX), a provider of heavy equipment for logistics companies , infrastructure construction and forestry conservation , announced that it has received equipment orders totaling $1.1 million which brings year-to-date sales up to $11.7 million.

Key Points: 
  • AmeraMex International, Inc. (OTCQB: AMMX), a provider of heavy equipment for logistics companies , infrastructure construction and forestry conservation , announced that it has received equipment orders totaling $1.1 million which brings year-to-date sales up to $11.7 million.
  • AmeraMex International sells, leases and rents heavy equipment to companies within multiple industries including construction, logistics, mining, and lumber.
  • AmeraMex, with a US and international customer base, has over 30 years of experience in heavy equipment sales and service.
  • Follow AmeraMex on Twitter @ammx_intl and visit the AmeraMex website, www.AMMX.net or www.hamreequipment.com for additional information and equipment videos.

DGAP-News: Pacific Green Appoints the Principal Contractor and Operations & Maintenance Provider for its Richborough Energy Park Battery Storage System in the UK

Retrieved on: 
Dienstag, Mai 31, 2022
Company, Electric Bond and Share Company v. Securities and Exchange Commission, National Utility Contractors Association, Annual report, Utility, News, Form 10-K, US, Water, General contractor, COVID-19, National Grid, Richborough Energy Park, Securities Exchange Act of 1934, BESS, CSP, Concentrated solar power, Risk, The Company, Maintenance, Operation, OTCQB, Security (finance), DE, Renewable energy, Airline, Pacific Green

DOVER, DE / ACCESSWIRE / May 31, 2022 / Pacific Green Technologies, Inc. (the "Company" or "Pacific Green", (OTCQB:PGTK)) announces that it has entered into an agreement with Instalcom Limited ("Instalcom") to be the principal contractor (the "Principal Contractor Agreement") for its 99.98 MW battery energy storage system ("BESS") in development at Richborough Energy Park in Kent, England.

Key Points: 
  • DOVER, DE / ACCESSWIRE / May 31, 2022 / Pacific Green Technologies, Inc. (the "Company" or "Pacific Green", (OTCQB:PGTK)) announces that it has entered into an agreement with Instalcom Limited ("Instalcom") to be the principal contractor (the "Principal Contractor Agreement") for its 99.98 MW battery energy storage system ("BESS") in development at Richborough Energy Park in Kent, England.
  • Scott Poulter, Pacific Green's Chief Executive, commented: "Instalcom has a 30 year track-record of delivering complex, large-scale energy infrastructure projects throughout the UK.
  • As well as the Principal Contractor Agreement, Pacific Green has also awarded Instalcom with an operations and maintenance contract (the "Operations & Maintenance Agreement") to provide comprehensive operations and maintenance services for Pacific Green's Richborough Energy Park.
  • The Operations & Maintenance Agreement will begin at the start of Richborough Energy Park's commercial operations via the UK's National Grid in June 2023.

Form 8.3 - The Vanguard Group, Inc.: Avast plc

Retrieved on: 
Dienstag, Mai 31, 2022
The Vanguard Group, Disclosure, Security (finance), Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Avast plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Avast plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

DGAP-News: Kadimastem Awarded Patent in Japan for AstroRx® For ALS and Drug Screening

Retrieved on: 
Montag, Mai 30, 2022
Diabetes, State Security Law in Bahrain, Company, Population, CSO, Parliament, Molecular genetics, Patient, Financial regulation, Weizmann Institute of Science, Regenerative medicine, TASE, Israel Prize, Clinical trial, Tel Aviv Stock Exchange, Emeritus, Cell, Stem cell, Patent, FDA, Projection, Brain, IND, Astrocyte, Spinal cord, Multiple sclerosis, Central nervous system, Technology, Safety, KDST, Risk, Movement, Japan Patent Office, ALS, Potency (pharmacology), Pharmaceutical industry

Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing a treatment for ALS, exploring one for multiple sclerosis and developing a potential cure for diabetes, has received a patent from the Japan Patent Office for AstroRx for the treatment of ALS and drug screening.

Key Points: 
  • Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing a treatment for ALS, exploring one for multiple sclerosis and developing a potential cure for diabetes, has received a patent from the Japan Patent Office for AstroRx for the treatment of ALS and drug screening.
  • Data showed that AstroRx delayed the progression of ALS by three months in ALSFRS-R measurement in both tested AstroRx doses.
  • In addition, we are exploring the possibilities of business partnerships with the pharmaceutical industry in Japan, both for AstroRx for ALS and IsletRx for diabetes.
  • AstroRx, the Company's lead product, is an astrocyte cell therapy in clinical development as a treatment for ALS.

Form 8.3 - The Vanguard Group, Inc.: HomeServe plc

Retrieved on: 
Montag, Mai 30, 2022
Homeserve, The Vanguard Group, Disclosure, Security (finance), Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: HomeServe plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc

Retrieved on: 
Montag, Mai 30, 2022
The Vanguard Group, ContourGlobal, Disclosure, Security (finance), Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: Meggitt plc

Retrieved on: 
Montag, Mai 30, 2022
The Vanguard Group, Meggitt, Disclosure, Security (finance), Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: Meggitt plc

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
    Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.
  • For a trust, the trustee(s), settlor and beneficiaries must be named.

Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.

Retrieved on: 
Montag, Mai 30, 2022
The Vanguard Group, NortonLifeLock, Disclosure, Security (finance), Auction, Life insurance

Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.

Key Points: 
  • Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
  • Dissemination of a Regulatory Announcement, transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • (a) Full name of discloser:
    (b) Owner or controller of interests and short positions disclosed, if different from 1(a):
    The naming of nominee or vehicle companies is insufficient.